Physician profile
Marisa Schoen
NPI 1114415197
$3,915.39
in general payments reported to CMS, 2019-2025
23 companies · $739 in 2025
The $739 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.97 · 2021: $434 · 2022: $938 · 2023: $1,228 · 2024: $526 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,492.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,008.80 | 2021-2025 | Clareon, Rocklatan, Argos |
| Johnson & Johnson Surgical Vision, INC. | $373.01 | 2022-2023 | Tecnis Iol |
| Carl Zeiss Meditec, INC. | $290.63 | 2022-2024 | |
| Glaukos Corporation | $271.30 | 2022-2023 | |
| New World Medical,INC. | $267.72 | 2023 | |
| Bausch & Lomb Americas INC. | $225.75 | 2023-2025 | Miebo, Vyzulta |
| Dompe US, INC. | $195.42 | 2024-2025 | Oxervate |
| Abbvie INC. | $192.29 | 2023-2025 | Lumigan, Alphagan P |
| Biotissue Holdings INC. | $181.48 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $147.51 | 2024-2025 | Xdemvy |
| Beaver-Visitec International, INC. | $133.65 | 2023 | |
| Sun Pharmaceutical Industries INC. | $112.63 | 2023-2025 | Cequa |
| Ani Pharmaceuticals, INC. | $94.20 | 2024 | Purified Cortrophin Gel |
| Carl Zeiss Meditec USA, INC. | $76.02 | 2023 | |
| Sight Sciences, INC. | $72.00 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $66.20 | 2025 | Vevye |
| Alexion Pharmaceuticals, INC. | $49.97 | 2020 | |
| Thea Pharma INC. | $33.66 | 2022-2024 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $32.60 | 2025 | Acthar |
| Oyster Point Pharma, INC. | $27.38 | 2023 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $24.38 | 2023 | Flarex |
| Rxsight INC | $22.44 | 2023 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Stryker Corporation | $16.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Schoen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.